Research programme: renal theraputics - TAGCyx Biotechnologies
Latest Information Update: 04 Aug 2023
At a glance
- Originator TagCyx Biotechnologies
- Class DNA; Oligonucleotides; Urologics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Renal failure
Most Recent Events
- 19 Jul 2023 Early research in Renal failure in Japan, prior to July 2023 (unspecified route)(TAGCyx Biotechnologies pipeline, July 2023)